Search research articles
Contact Us
Filters
Showing results (311-320 of 339) with videos related to
Page
of 34
Sort By:
Leukemia & Lymphoma
|
February 27, 2020
Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy
Rory M Shallis, Maximilian Stahl, Wei Wei, et al.
Wiener Klinische Wochenschrift
|
July 20, 2019
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research
Klaus Geissler, Eva Jäger, Agnes Barna, et al.
BMC Cancer
|
September 24, 2022
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes
Tamara K Moyo, Jason H Mendler, Raphael Itzykson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2017
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents
Sophie Park, Jean-François Hamel, Andrea Toma, et al.
The New England Journal of Medicine
|
November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell Therapy
Guido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2024
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, et al.
Blood
|
February 1, 2023
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes
Amer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, et al.
Haematologica
|
June 24, 2009
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes
Arjan A van de Loosdrecht, Canan Alhan, Marie Christine Béné, et al.
Blood
|
July 29, 2024
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2023
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
Esther Natalie Oliva, Marta Riva, Pasquale Niscola, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 339) with videos related to
Sort By:
Page
of 34
Leukemia & Lymphoma
|
February 27, 2020
Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy
Rory M Shallis, Maximilian Stahl, Wei Wei, et al.
Wiener Klinische Wochenschrift
|
July 20, 2019
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research
Klaus Geissler, Eva Jäger, Agnes Barna, et al.
BMC Cancer
|
September 24, 2022
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes
Tamara K Moyo, Jason H Mendler, Raphael Itzykson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2017
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents
Sophie Park, Jean-François Hamel, Andrea Toma, et al.
The New England Journal of Medicine
|
November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell Therapy
Guido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2024
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, et al.
Blood
|
February 1, 2023
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes
Amer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, et al.
Haematologica
|
June 24, 2009
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes
Arjan A van de Loosdrecht, Canan Alhan, Marie Christine Béné, et al.
Blood
|
July 29, 2024
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2023
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
Esther Natalie Oliva, Marta Riva, Pasquale Niscola, et al.
Page
of 34